18:02 23 May 2025
Europe’s Biotech Sector Calls for Clear Rules Amid Green Transition
As the EU accelerates its green transition, the biotech sector is growing fast, but outdated regulations are holding it back. Companies developing biosolutions such as bioplastics, biofuels, and biological crop protection face approval times of 7-9 years, threatening innovation and investment.
“Europe’s biotech firms don’t lose on innovation – they lose to bureaucracy,” says Danish MEP Morten Løkkegaard, who is leading calls for a unified “Bio Act” to modernize EU legislation. Current rules, designed for the chemical era, no longer match the sector’s needs.
The European Biosolutions Coalition, representing 11 industry groups, urges the EU to create clear, predictable frameworks to attract investors and support market entry. Without legal clarity, Europe risks missing leadership in one of its most promising industries.
A new EU bioeconomy strategy is expected in late 2025, with draft legislation likely in early 2026 under Denmark’s EU presidency – a country seen as a biotech frontrunner.
